News

Deal Announcements

FoldRx Pharmaceuticals Closes $29 Million VC Funding

Wednesday, June 16, 2010 5:53:00 AM PDT | VentureDeal Staff
Cambridge, Massachusetts  --  FoldRx Pharmaceuticals has garnered $29 million in a new round of institutional venture capital investment.

FoldRx is developing "disease modifying drug therapies for diseases of protein mis-folding and amyloidosis."

There were numerous investors in the round. The company said it would use the funding proceeds to continue advancing the development of its tafamidis product.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1